DZ3207A1 - Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant. - Google Patents

Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant.

Info

Publication number
DZ3207A1
DZ3207A1 DZ003207A DZ003207A DZ3207A1 DZ 3207 A1 DZ3207 A1 DZ 3207A1 DZ 003207 A DZ003207 A DZ 003207A DZ 003207 A DZ003207 A DZ 003207A DZ 3207 A1 DZ3207 A1 DZ 3207A1
Authority
DZ
Algeria
Prior art keywords
suspension
packaging containing
tixocortol pivalate
mouthwash
pharyngeal
Prior art date
Application number
DZ003207A
Other languages
English (en)
French (fr)
Inventor
Bernard Doat
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DZ3207A1 publication Critical patent/DZ3207A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Detergent Compositions (AREA)
  • Cartons (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Polymerisation Methods In General (AREA)
  • Vehicle Body Suspensions (AREA)
  • Wrapping Of Specific Fragile Articles (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DZ003207A 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant. DZ3207A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9909556A FR2796553B1 (fr) 1999-07-22 1999-07-22 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant
PCT/FR2000/001987 WO2001007053A1 (fr) 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire a base de celle-ci et conditionnement la contenant

Publications (1)

Publication Number Publication Date
DZ3207A1 true DZ3207A1 (fr) 2001-02-01

Family

ID=9548429

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003207A DZ3207A1 (fr) 1999-07-22 2000-07-07 Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant.

Country Status (25)

Country Link
EP (1) EP1200096B1 (cs)
JP (1) JP2003505421A (cs)
KR (1) KR100718211B1 (cs)
AT (1) ATE269088T1 (cs)
AU (1) AU6296700A (cs)
BG (1) BG106358A (cs)
BR (1) BR0012671A (cs)
CA (1) CA2378390C (cs)
CZ (1) CZ2002144A3 (cs)
DE (1) DE60011620T2 (cs)
DK (1) DK1200096T3 (cs)
DZ (1) DZ3207A1 (cs)
EE (1) EE200200039A (cs)
ES (1) ES2219366T3 (cs)
FR (1) FR2796553B1 (cs)
HK (1) HK1046850B (cs)
HU (1) HUP0202055A3 (cs)
IS (1) IS6228A (cs)
MX (1) MXPA02000834A (cs)
NO (1) NO20020252L (cs)
OA (1) OA11993A (cs)
PL (1) PL354100A1 (cs)
PT (1) PT1200096E (cs)
SK (1) SK762002A3 (cs)
WO (1) WO2001007053A1 (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5317512B2 (ja) * 2008-03-31 2013-10-16 小林製薬株式会社 含嗽用組成物
JP5461785B2 (ja) * 2008-03-31 2014-04-02 小林製薬株式会社 繰り返し感染予防用の医薬組成物
JP2013123450A (ja) * 2011-12-13 2013-06-24 Akihiro Sato 金属錯体イオン液を応用した塵肺の療養方法、および、咽頭・気管・気管支の療養方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877781A (en) * 1987-09-30 1989-10-31 Peter G. LaHaye Medical dispenser and preparation for inflamed tissue
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
WO1997020578A1 (en) * 1995-12-04 1997-06-12 University Of Miami Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance

Also Published As

Publication number Publication date
FR2796553B1 (fr) 2001-09-28
HK1046850A1 (en) 2003-01-30
WO2001007053A1 (fr) 2001-02-01
CZ2002144A3 (cs) 2002-06-12
MXPA02000834A (es) 2003-07-14
NO20020252D0 (no) 2002-01-17
AU6296700A (en) 2001-02-13
CA2378390A1 (en) 2001-02-01
NO20020252L (no) 2002-01-17
BG106358A (bg) 2002-08-30
IS6228A (is) 2002-01-15
EP1200096A1 (fr) 2002-05-02
KR20020012010A (ko) 2002-02-09
KR100718211B1 (ko) 2007-05-15
DK1200096T3 (da) 2004-09-13
HUP0202055A2 (en) 2002-09-28
DE60011620D1 (de) 2004-07-22
DE60011620T2 (de) 2005-07-21
ES2219366T3 (es) 2004-12-01
HK1046850B (zh) 2004-12-31
OA11993A (fr) 2006-04-18
ATE269088T1 (de) 2004-07-15
BR0012671A (pt) 2002-04-09
HUP0202055A3 (en) 2009-03-30
EE200200039A (et) 2003-04-15
EP1200096B1 (fr) 2004-06-16
FR2796553A1 (fr) 2001-01-26
SK762002A3 (en) 2002-08-06
PL354100A1 (en) 2003-12-29
CA2378390C (en) 2008-09-23
PT1200096E (pt) 2004-10-29
JP2003505421A (ja) 2003-02-12

Similar Documents

Publication Publication Date Title
BR9902086A (pt) Formulações farmacêuticas.
DE60027606D1 (de) Polyphenolisches protein enthaltende bioadhäsive zusammensetzung
AR015413A1 (es) Composicion cosmetica util especialmente para el blanqueo de la piel
PE20020108A1 (es) Estructuras y composiciones que aumentan la estabilidad de activos de peroxido
MXPA03011006A (es) Compuestos de cicloalquil urea benzo-fusionados 1,4-disustituidos.
TR199801114T2 (xx) Bir hidrofobik s�v� madde i�eren kararl� em�lsiyon.
FR2765479B1 (fr) Composition lavantes et conditionnantes a base de silicone et de gomme de galactomannane hydrophobe
MY133507A (en) New peroxy-carboxylic acid and aqueous compositions thereof
SI0688771T1 (en) Use of lactam compounds as pharmaceutical agents
DE60114043D1 (de) Zahnputzzusammensetzung
BR9902084A (pt) Heterociclos.
EE200100641A (et) Pürasinooniühendid, trombiini inhibeeriv farmatseutiline kompositsioon ja meetod trombitekke inhibeerimiseks veres
DZ3207A1 (fr) Suspension de tixocortol pivalate, collutoire à base de celle-ci et conditionnement la contenant.
BR9910454A (pt) Preparações efervescentes
ID25478A (id) Agonis 5-ht1f
PE20001223A1 (es) Composiciones blanqueadoras
BR9803313A (pt) Sais de poliamina cìclicos.
AR012481A1 (es) Composiciones para el tratamiento del cabello
CA2346567A1 (fr) Procede de preparation d'une solution pour pulverisation nasale contenant une ou plusieurs hormones sexuelles et une cyclodextrine
ATE325787T1 (de) 5,7,7-trimethyloctannitril
DE59908481D1 (de) Wasch- und reinigungsmittelformkörper/verpackung-kombination
ATE403416T1 (de) Verdicktes kationisches kosmetisches mittel inulin enthaltend
ES2182109T3 (es) Composiciones de agente blanqueante
FR2800736B1 (fr) Derives d'oligobenzimidazoles, les compositions les contenant et leurs utilisations
SI0987268T1 (en) Pharmaceutical agents containing epothilone A-N-oxide and/or epothilone B-N-oxide